Cookies on this website

We use cookies to ensure that we give you the best experience on our website. If you click 'Accept all cookies' we'll assume that you are happy to receive all cookies and you won't see this message again. If you click 'Reject all non-essential cookies' only necessary cookies providing core functionality such as security, network management, and accessibility will be enabled. Click 'Find out more' for information on how to change your cookie settings.

Publications

Optimising DTwP-containing vaccine infant immunisation schedules in Uganda and Nepal (OptImms): two open-label, non-inferiority, randomised controlled trials.

Bijukchhe SM. et al, (2026), Lancet Infect Dis

Report of a one-day convening on regulatory science, practices, and innovative approaches to facilitate approval of novel combination vaccines.

Hausdorff WP. et al, (2026), Vaccine, 75

Severe necrotizing soft tissue infections (SENSEI) study: Protocol for a multi-centered audit.

Yoshimura R. et al, (2026), JPRAS Open, 48, 331 - 336

The Epidemiology and Clinical Burden of Human Adenovirus Respiratory Infections Among Hospitalized Children Under 5 Years in Jordan.

Abu-Helalah M. et al, (2026), Pediatr Infect Dis J, 45, 229 - 235

Securing the future of immunisation: ESCMID’s vision

Ramasamy MN. et al, (2026), CMI Communications, 3, 105167 - 105167

Maternal perspectives on the RSV vaccine (Abrysvo): a thematic analysis of survey findings from the first season of implementation in England and Scotland.

O'Hagan S. et al, (2026), Arch Dis Child

Pooled analysis of PCV13 efficacy from controlled human infection trials in Malawi and the UK.

Kudowa E. et al, (2026), NPJ Vaccines

An Adenoviral Vectored Vaccine Protects Mice Against Aerosol Challenge with Yersinia pestis.

Dold C. et al, (2026), Mol Ther

Experiences of participant engagement from an African and Asian ancestry cohort during a clinical research study of lymph node responses to influenza immunisation in the United Kingdom

Metcalf D. et al, (2026)

Predicting Salmonella Typhi incidence using prevalence metrics from sentinel studies of community-onset bloodstream infections

Hagedoorn N. et al, (2026)

Controlled human pneumococcal infection in the Netherlands: Colonisation, antibody responses and the impact of viral co-infection.

van Beek LF. et al, (2026), J Infect, 92

Biobanking knowledge and donation willingness among musculoskeletal patients in England: a multisite cross-sectional study.

Boakye Serebour T. et al, (2026), BMJ Open, 16

Maternal iron status and total immunoglobulin-G influence transplacental antibody transfer across eight diverse geographical settings.

Tiley KS. et al, (2026), Vaccine, 73

Enablers and barriers to participation in vaccine trials: a narrative synthesis.

Daniel N. et al, (2026), Vaccine, 73

The effect of pneumococcal conjugate vaccine and pneumococcal polysaccharide vaccine on nasopharyngeal colonisation following human infection challenge with serotype 3 and serotype 6B (PREVENTING PNEUMO 2): a double-masked, randomised, controlled, phase 4 trial.

Liatsikos K. et al, (2026), Lancet Microbe

Load More

1
2
3
4
5
6
7
...
»